Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients
2020 · Journal of Translational Medicine · 37 citations
https://doi.org/10.1186/s12967-020-02285-0
S
Serena Zanotta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
608
Citations
16
h-index
19
i10-index
Serena Zanotta is an academic researcher from Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale". The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 16, co-authored 37 publications.
ORCID: 0000-0003-4917-2076Papers by this author
worksSubclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fraction
2020 · BMC Pulmonary Medicine · 22 citations
https://doi.org/10.1186/s12890-020-1099-9
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-018-0952-7
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123
2024 · International Journal of Molecular Sciences · 5 citations
https://doi.org/10.3390/ijms25031454
Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm
2025 · International Journal of Molecular Sciences · 3 citations
https://doi.org/10.3390/ijms26062732
Additional file 2: of Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7422461
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat